Junqing Luan

机构：Chinese PLA General Hospital, Chinese General Hospital College of Nursing and Liberal Arts

发表论文 14 篇 · 总被引 241 次 · h-index 6

代表论文

• Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial (2021 · Hepatology International · 被引 113)
• Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer (2022 · Frontiers in Oncology · 被引 46)
• Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC (2021 · Hepatology Communications · 被引 30)
• Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy (2022 · Frontiers in Immunology · 被引 22)
• Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study (2025 · Cancer Immunology Immunotherapy · 被引 13)
• Tislelizumab plus tyrosine kinase inhibitor versus active surveillance in patients with ablated high-risk hepatocellular carcinoma: An open-label, parallel controlled, prospective cohort study. (2024 · Journal of Clinical Oncology · 被引 6)